期刊文献+

常染色体显性遗传腓骨肌萎缩症的临床与基因突变特点 被引量:4

Clinical features and gene mutations of Chinese patients with autosomal dominant Charcot-Marie-Tooth disease
下载PDF
导出
摘要 目的探讨常染色体显性遗传腓骨肌萎缩症(CMT)患者的临床与基因突变的特点。方法对43个常染色体显性遗传CMT家系共106例患者的临床表现、电生理和病理特点进行回顾性分析,并进行PMP22的大片段重复突变和PMP22、MPZ、SIMPLE、EGR2、RAB7、NEFL、MFN2、Hsp27及Hsp22基因突变分析。结果 CMT1A和CMT1B致病基因分别为PMP22的大片段重复突变和MPZ基因,这两型患者起病较早,临床表现多见起始于下肢远端的肌无力萎缩,伴感觉减退或缺失,神经系统检查可见小腿肌肉明显萎缩,膝、踝反射减低或消失,弓形足,神经电生理检查示神经传导速度减慢,病理改变可见髓鞘脱失。CMT2A2、CMT2F和CMT2L致病基因分别为MFN2、Hsp27及Hsp22基因,发病率较CMT1低,发病年龄比CMT1较迟,临床症状与CMT1相比,运动系统受累较感觉系统更明显,神经传导速度常在正常范围,病理改变呈轴索变性。结论基因突变分析结果与临床特点一致,准确性高、损伤小,可早期诊断,值得广泛应用于临床,特别是有家族史的患者或高危亲属。 Objective To analyze the characteristics of the clinical features and the gene mutations between Chinese patients with autosomal dominant Charcot-Marie-Tooth disease.Methods The clinical manifestations,electrophysiological and pathological investigations of patients with autosomal dominant Charcot-Marie-Tooth were analyzed retrospectively.One hundred and six CMT patients underwent mutation analysis of PMP22 duplication and PMP22,MPZ,SIMPLE,EGR2,RAB7,NEFL,MFN2,Hsp27 and Hsp22.Results CMT1A was caused by PMP22 duplication,and CMT1B was caused by MPZ mutation.In those patients,the age of onset were earlier.The most frequently first symptom was weakness and atrophy in lower limbs with hypesthesia.Physical examination showed distal limb weakness and wasting,and taplipes cavus in all of them.Electromyogram and nerve conduction velocity showed slow nerve conduction.Pathological examination showed demyelination.CMT2A2 was caused by MFN2 mutation,CMT2F was caused by Hsp27 mutation,and CMT2L was caused by Hsp22 mutation.Compared with CMT1,patients of CMT2 were less frequent,the age of onset were later,motor disability was more sever than sensory aisability.Electromyogram and nerve conduction velocity was normal.Pathological examination showed axonal denaturation.Conclusions In this study,the results of the mutation screening were consistent with the clinical features.Mutation screening has the character of high accuracy,little harm and can help to diagnosis earlier,so it suggestes to be performed widely in the clinic especially to the patients who has family history or to the lineal relatives.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2011年第8期705-707,共3页 Journal of Apoplexy and Nervous Diseases
关键词 腓骨肌萎缩症 常染色体显性遗传 临床 突变分析 Charcot-Marie-Tooth disease Autosomal dominant Clinical Mutation analysis
  • 相关文献

参考文献4

二级参考文献63

  • 1张如旭,唐北沙,资晓宏,罗巍,许波,冯永,胡正茂,龙志高,吴鼎文,贺定华,李小波.腓骨肌萎缩症伴神经性耳聋一家系临床和分子遗传学分析[J].中华神经科杂志,2004,37(4):319-322. 被引量:8
  • 2张付峰,唐北沙,沈岩,赵国华,夏昆,赵一强,陈彪,张成,潘乾,蔡芳,刘小民,罗巍,张如旭,郭鹏.实时荧光定量PCR在周围髓鞘蛋白22基因重复或缺失检测中的应用[J].中华医学遗传学杂志,2005,22(5):537-540. 被引量:8
  • 3Warner LE, Garcia CA, Lupski JR. Hereditary peripheral neuropathies : clinical forms, genetics, and molecular mechanisms. Annu Rev Med, 1999.50:263-275. 被引量:1
  • 4Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types Ⅰ and Ⅱ. Brain, 1980,103: 259-280. 被引量:1
  • 5Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci, 2003,4: 714-726. 被引量:1
  • 6Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet, 2004,36: 449-451. 被引量:1
  • 7Kijima K, Numakura C, Izumino H,et al. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet, 2005,116:23-27. 被引量:1
  • 8Chung KW, Kim SB. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 ( MFN2 ) mutations. Brain, 2006,129:2103-2118. 被引量:1
  • 9Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci, 2001,114: 867-874. 被引量:1
  • 10Neusch C, Senderek J, Eggermann T, et al. Mitofusin 2 gene mutation ( R94Q ) causing severe early-onset axonal polyneuropathy (CMT2A). Eur J Neurol, 2007,14 : 575-577. 被引量:1

共引文献25

同被引文献13

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部